Ginkgo Bioworks Holdings Inc. shares DNA were rising more than 5% in Monday’s premarket trading after the company said it was collaborating with Merck & Co. Inc. MRK on improvements in biologic manufacturing. Ginkgo plans to use its abilities in cell engineering, ultra high-throughput multiplexed screening, protein characterization and process optimization to boost yields and drive improvements in production efficiency.
. Ginkgo Bioworks Holdings Inc. shares DNA were rising more than 5% in Monday’s premarket trading after the company said it was collaborating with Merck & Co. Inc. MRK on improvements in biologic manufacturing. Ginkgo plans to use its abilities in cell engineering, ultra high-throughput multiplexed screening, protein characterization and process optimization to boost yields and drive improvements in production efficiency.